Early buyers will receive 10% customization on this report.
The global microbial identification market is estimated at $896.5 million in 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019.
The report segments this market on the basis of products, methods, applications, end users, and geographies. Among various applications, human disease diagnosis is expected to account for the largest share in 2014, while the pharmaceutical applications is forecasted to be the fastest-growing segment in the microbial identification market.
Factors such as high prevalence of infectious diseases, technological advancements in products, growing food safety concerns, government initiatives, and higher healthcare expenditure in the emerging geographies are driving the growth of the microbial identification market. Furthermore, owing to the collaborative working of various companies and continuous advancements in technologies, new and innovative products are being launched in the market which is another major factor providing impetus for the growth of this market.
Based on geography, the global microbial identification market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014.
The prominent players in the microbial identification market are bioMérieux SA (France), Bruker Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Siemens healthcare (Germany).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
